• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极长链酰基辅酶 A 脱氢酶缺乏症:通过新生儿筛查发现的患者偶然脂肪负荷的影响。

Very long-chain acyl-CoA dehydrogenase deficiency: the effects of accidental fat loading in a patient detected through newborn screening.

机构信息

Department of Pediatrics, Section of Biochemical Genetics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

出版信息

J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S187-90. doi: 10.1007/s10545-009-1143-7. Epub 2009 Apr 4.

DOI:10.1007/s10545-009-1143-7
PMID:19333779
Abstract

Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is an autosomal recessive disorder of fatty acid oxidation. The majority of patients with VLCADD can be detected through newborn screening (NBS) with elevated levels of the tetradecanoyl carnitine species. An 11-month-old infant, diagnosed with late-onset VLCADD (genotype: T848C/G1322A) through newborn screening at birth, was admitted with emesis, severe lethargy, limpness in extremities, loss of muscle tone and an elevated CK level. He was mistakenly given Ketocal formula (about 8 g/kg per day long-chain fat-over six times his usual intake) instead of his usual Monogen formula for 2.5 days before being admitted. Once admitted, he was started on Monogen and IV (10% dextrose) fluids. He was discharged home after four days in the hospital without any sequelae of this accidental fat loading event. The report highlights several important points about this particular case and more generally about patients with VLCADD detected through NBS: (1) the amount of time in which patients might become severely symptomatic and the nature of these symptoms after fat loading; (2) the time frame for complete recovery after beginning of treatment; (3) the importance of alerting home-care companies and families about formula delivery errors and their repercussions.

摘要

长链酰基辅酶 A 脱氢酶缺乏症(VLCADD)是一种脂肪酸氧化的常染色体隐性遗传病。大多数 VLCADD 患者可通过新生儿筛查(NBS)检测到,筛查结果为十四烷酰肉碱水平升高。一名 11 月龄婴儿在出生时通过新生儿筛查被诊断为迟发性 VLCADD(基因型:T848C/G1322A),因呕吐、严重嗜睡、四肢无力、肌张力丧失和 CK 水平升高而入院。在入院前的 2.5 天里,他被错误地给予了 Ketocal 配方(约 8 g/kg 长链脂肪,是他通常摄入量的六倍以上),而不是他通常的 Monogen 配方。入院后,他开始使用 Monogen 和 IV(10%葡萄糖)补液。在住院四天后,他没有出现任何因这次意外脂肪负荷事件导致的后遗症而出院。该报告强调了这个特殊病例以及更普遍地通过 NBS 检测到的 VLCADD 患者的几个重要要点:(1)患者可能出现严重症状的时间以及脂肪负荷后这些症状的性质;(2)开始治疗后完全康复的时间框架;(3)提醒家庭护理公司和家庭注意配方交付错误及其影响的重要性。

相似文献

1
Very long-chain acyl-CoA dehydrogenase deficiency: the effects of accidental fat loading in a patient detected through newborn screening.极长链酰基辅酶 A 脱氢酶缺乏症:通过新生儿筛查发现的患者偶然脂肪负荷的影响。
J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S187-90. doi: 10.1007/s10545-009-1143-7. Epub 2009 Apr 4.
2
Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.中国患者的极长链酰基辅酶A脱氢酶缺乏症:八例报告,包括一例产前诊断病例
Eur J Med Genet. 2015 Mar;58(3):134-9. doi: 10.1016/j.ejmg.2015.01.005. Epub 2015 Jan 31.
3
Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.新生儿极长链酰基辅酶 A 脱氢酶缺乏症筛查对遗传、酶学和临床结局的影响。
J Inherit Metab Dis. 2019 May;42(3):414-423. doi: 10.1002/jimd.12075. Epub 2019 Apr 8.
4
Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.在美国,对极长链酰基辅酶A脱氢酶(VLCAD)缺乏症新生儿筛查呈阳性的个体中反复出现的ACADVL分子发现。
Mol Genet Metab. 2015 Nov;116(3):139-45. doi: 10.1016/j.ymgme.2015.08.011. Epub 2015 Sep 2.
5
Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.极长链酰基辅酶 A 脱氢酶缺乏症的分子和细胞病理学。
Mol Genet Metab. 2013 May;109(1):21-7. doi: 10.1016/j.ymgme.2013.02.002. Epub 2013 Feb 13.
6
Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.极长链酰基辅酶 A 脱氢酶缺乏症患者的临床和生化结局。
Mol Genet Metab. 2019 May;127(1):64-73. doi: 10.1016/j.ymgme.2019.04.001. Epub 2019 Apr 16.
7
The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.基于中链甘油三酯的配方奶粉Lipistart在长链脂肪酸疾病饮食治疗中的安全性:一项I期研究。
J Pediatr Endocrinol Metab. 2018 Mar 28;31(3):297-304. doi: 10.1515/jpem-2017-0426.
8
Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.新生儿筛查疑诊极长链酰基辅酶 A 脱氢酶缺乏症的婴儿。
Mol Genet Metab. 2014 Apr;111(4):484-92. doi: 10.1016/j.ymgme.2014.01.009. Epub 2014 Jan 23.
9
The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).极长链酰基辅酶 A 脱氢酶缺乏症(VLCADD)的诊断挑战。
J Inherit Metab Dis. 2018 Nov;41(6):1169-1178. doi: 10.1007/s10545-018-0245-5. Epub 2018 Sep 7.
10
[Clinical features and ACADVL gene mutation spectrum analysis of 11 Chinese patients with very long chain acyl-CoA dehydrogenase deficiency].11例中国极长链酰基辅酶A脱氢酶缺乏症患者的临床特征及ACADVL基因突变谱分析
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):262-7.

引用本文的文献

1
Roux-en-Y Vitamins Are Important.Roux-en-Y术式中的维生素很重要。
J Gen Intern Med. 2023 Mar;38(4):1072-1073. doi: 10.1007/s11606-022-07989-1. Epub 2023 Jan 3.
2
Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.线粒体脂肪酸氧化障碍的管理和诊断:重点关注极长链酰基辅酶 A 脱氢酶缺乏症。
J Hum Genet. 2019 Feb;64(2):73-85. doi: 10.1038/s10038-018-0527-7. Epub 2018 Nov 6.

本文引用的文献

1
A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency.极长链酰基辅酶A脱氢酶缺乏症管理的德尔菲临床实践方案。
Mol Genet Metab. 2009 Mar;96(3):85-90. doi: 10.1016/j.ymgme.2008.09.008. Epub 2009 Jan 20.
2
Effects of a fat load and exercise on asymptomatic VLCAD deficiency.脂肪负荷与运动对无症状性极长链酰基辅酶A脱氢酶缺乏症的影响。
J Inherit Metab Dis. 2007 Jun;30(3):405. doi: 10.1007/s10545-007-0548-4. Epub 2007 Apr 24.
3
Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry.
串联质谱法用于新生儿极长链酰基辅酶A脱氢酶缺乏症筛查的陷阱
J Pediatr. 2006 Jul;149(1):128-30. doi: 10.1016/j.jpeds.2006.02.037.
4
VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis.极长链酰基辅酶A脱氢酶缺乏症:新生儿筛查中的陷阱及通过突变分析确诊
Mol Genet Metab. 2006 Jun;88(2):166-70. doi: 10.1016/j.ymgme.2005.12.012. Epub 2006 Feb 20.
5
MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency.基于串联质谱的新生儿及家庭筛查可检测出无症状的极长链酰基辅酶A脱氢酶缺乏症患者。
J Pediatr. 2003 Sep;143(3):335-42. doi: 10.1067/S0022-3476(03)00292-0.
6
Management of fatty acid oxidation disorders: a survey of current treatment strategies.脂肪酸氧化障碍的管理:当前治疗策略的调查
J Am Diet Assoc. 2002 Dec;102(12):1800-3. doi: 10.1016/s0002-8223(02)90386-x.
7
Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.通过婴儿的新生儿筛查卡片诊断极长链酰基辅酶A脱氢酶缺乏症。
Pediatrics. 2001 Jul;108(1):E19. doi: 10.1542/peds.108.1.e19.
8
Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.在极长链酰基辅酶A脱氢酶缺乏症中基因型与疾病表型的明确相关性。
Am J Hum Genet. 1999 Feb;64(2):479-94. doi: 10.1086/302261.